biosensors

The method uses graphene-coated silica particles fused to complementary RNA to register impedance changes in the presence of viruses.

A team of Swedish researchers has received $3.3 million to develop a new nanotechnology platform for detecting blood-borne markers in lung and breast cancer.

The company's core technology involves the use of cultured cells as biosensors to detect expression levels of genes associated with the disease.

The team showed the approach could successfully monitor cytokines in infants after heart surgery, and is involved now in a larger clinical study expanding this research. 

British biotechnology firm QuantuMDx last week announced an agreement with the Genome Institute of Singapore that will see the partners develop a genetic test specific to Asian populations on QuantuMDx's nanowire array-based platform.

NEW YORK (GenomeWeb News) – Mediomics has reeled in a $997,251 grant from the National Cancer Institute to continue developing technologies for monitoring the titer and quality of recombinant biologics, the company said today.

Attana recently announced that it has been certified according to the International Organization for Standardization's 9001:2008 quality management systems standard.

Biomagnetics Diagnostics intends to develop a handheld, integrated optical biosensor for rapid diagnosis of HIV/AIDS, malaria, tuberculosis, and other pathogens.

STC.UNM, the technology-transfer arm for UNM, was lead institution on the agreement, under which Adaptive Methods may obtain an exclusive license to manufacture and sell a variety of products incorporating the biosensor technology.

Tech Transfer Tidbits

Premium

Pfizer and UCL to develop stem-cell therapies for AMD; Clarient licenses breast cancer biomarkers from Indiana U; Nanosys and Harvard to outlicense nanowire IP; Luminex settles with SUNY and U of Illinois, and more …

Pages

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.